258 related articles for article (PubMed ID: 12693379)
1. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
[TBL] [Abstract][Full Text] [Related]
2. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
Juan W; Nakazawa M; Watanabe K; Ma M; Wahed MI; Hasegawa G; Naito M; Yamamoto T; Fuse K; Kato K; Kodama M; Aizawa Y
Mol Cell Biochem; 2003 Sep; 251(1-2):77-82. PubMed ID: 14575307
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Shirai K; Watanabe K; Ma M; Wahed MI; Inoue M; Saito Y; Suresh PS; Kashimura T; Tachikawa H; Kodama M; Aizawa Y
Mol Cell Biochem; 2005 Jan; 269(1-2):137-42. PubMed ID: 15786726
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of quinapril with enalapril in rats with heart failure.
Watanabe K; Ma M; Wen J; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
Pharmacology; 2004 Jul; 71(3):157-61. PubMed ID: 15161998
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Watanabe K; Saito Y; Ma M; Wahed M; Abe Y; Hirabayashi K; Narasimman G; Wen J; Suresh P; Ali F; Shirai K; Soga M; Nagai Y; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S105-9. PubMed ID: 14871039
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
Ma M; Watanabe K; Wahed MI; Inoue M; Sekiguchi T; Kouda T; Ohta Y; Nakazawa M; Yoshida Y; Yamamoto T; Hanawa H; Kodama M; Fuse K; Aizawa Y
J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
9. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Watanabe K; Ohta Y; Nakazawa M; Higuchi H; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
Br J Pharmacol; 2000 Aug; 130(7):1489-95. PubMed ID: 10928949
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
11. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure.
Vaile JC; Chowdhary S; Osman F; Ross HF; Fletcher J; Littler WA; Coote JH; Townend JN
Clin Sci (Lond); 2001 Dec; 101(6):559-66. PubMed ID: 11724639
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
[TBL] [Abstract][Full Text] [Related]
15. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Bastien NR; Juneau AV; Ouellette J; Lambert C
Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
[TBL] [Abstract][Full Text] [Related]
16. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
Turcani M; Rupp H
Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
[TBL] [Abstract][Full Text] [Related]
17. [Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study].
Skvortsov AA; Nasonova SN; Sychev AV; Orlova IaA; Baklanova NA; Masenko VP; Mareev VIu; Belenkov IuN
Kardiologiia; 2006; 46(7):33-51. PubMed ID: 16883264
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
Sata N; Tanaka Y; Suzuki S; Kamimura R; Mifune H; Nakamura K; Miyahara K; Arima T
Circ J; 2003 Dec; 67(12):1053-8. PubMed ID: 14639023
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
20. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Sebeková K; Lill M; Boor P; Heidland A; Amann K
Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
